{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T09:57:30Z","timestamp":1768989450483,"version":"3.49.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100010849","name":"Hope For Vision","doi-asserted-by":"publisher","award":["Grant"],"award-info":[{"award-number":["Grant"]}],"id":[{"id":"10.13039\/100010849","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010849","name":"Hope For Vision","doi-asserted-by":"publisher","award":["Grant"],"award-info":[{"award-number":["Grant"]}],"id":[{"id":"10.13039\/100010849","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006955","name":"Office of Extramural Research, National Institutes of Health","doi-asserted-by":"publisher","award":["R01EY023666; R01EY026643; R01EY031492; P30EY14801; NS098740; NS120028;"],"award-info":[{"award-number":["R01EY023666; R01EY026643; R01EY031492; P30EY14801; NS098740; NS120028;"]}],"id":[{"id":"10.13039\/100006955","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006955","name":"Office of Extramural Research, National Institutes of Health","doi-asserted-by":"publisher","award":["R01EY023666; R01EY026643; R01EY031492; P30EY14801; NS098740; NS120028;"],"award-info":[{"award-number":["R01EY023666; R01EY026643; R01EY031492; P30EY14801; NS098740; NS120028;"]}],"id":[{"id":"10.13039\/100006955","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006955","name":"Office of Extramural Research, National Institutes of Health","doi-asserted-by":"publisher","award":["R01EY023666; R01EY026643; R01EY031492; P30EY14801; NS098740; NS120028;"],"award-info":[{"award-number":["R01EY023666; R01EY026643; R01EY031492; P30EY14801; NS098740; NS120028;"]}],"id":[{"id":"10.13039\/100006955","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Miami Project to Cure Paralysis","award":["Support"],"award-info":[{"award-number":["Support"]}]},{"DOI":"10.13039\/100000928","name":"Welch Foundation","doi-asserted-by":"publisher","award":["F-0652"],"award-info":[{"award-number":["F-0652"]}],"id":[{"id":"10.13039\/100000928","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013709","name":"Dell Medical School, University of Texas at Austin","doi-asserted-by":"publisher","award":["Texas Health Catalyst program"],"award-info":[{"award-number":["Texas Health Catalyst program"]}],"id":[{"id":"10.13039\/100013709","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The sigma 2 receptor (\u03c3<jats:sub>2<\/jats:sub>R) was recently identified as an endoplasmic reticulum (ER) membrane protein known as transmembrane protein 97 (TMEM97). Studies have shown that \u03c3<jats:sub>2<\/jats:sub>R\/TMEM97 binding compounds are neuroprotective, suggesting a role of \u03c3<jats:sub>2<\/jats:sub>R\/TMEM97 in neurodegenerative processes. To understand the function of \u03c3<jats:sub>2<\/jats:sub>R\/TMEM97 in neurodegeneration pathways, we characterized ischemia-induced retinal ganglion cell (RGC) degeneration in <jats:italic>TMEM97<\/jats:italic><jats:sup><jats:italic>\u2212\/\u2212<\/jats:italic><\/jats:sup> mice and found that RGCs in <jats:italic>TMEM97<\/jats:italic><jats:sup><jats:italic>\u2212\/\u2212<\/jats:italic><\/jats:sup> mice are resistant to degeneration. In addition, intravitreal injection of a selective \u03c3<jats:sub>2<\/jats:sub>R\/TMEM97 ligand DKR-1677 significantly protects RGCs from ischemia-induced degeneration in wildtype mice. Our results provide conclusive evidence that \u03c3<jats:sub>2<\/jats:sub>R\/TMEM97 plays a role to facilitate RGC death following ischemic injury and that inhibiting the function of \u03c3<jats:sub>2<\/jats:sub>R\/TMEM97 is neuroprotective. This work is a breakthrough toward elucidating the biology and function of \u03c3<jats:sub>2<\/jats:sub>R\/TMEM97 in RGCs and likely in other \u03c3<jats:sub>2<\/jats:sub>R\/TMEM97 expressing neurons. Moreover, these findings support future studies to develop new neuroprotective approaches for RGC degenerative diseases by inhibiting \u03c3<jats:sub>2<\/jats:sub>R\/TMEM97.<\/jats:p>","DOI":"10.1038\/s41598-022-24537-3","type":"journal-article","created":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T13:02:14Z","timestamp":1669899734000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["\u03c32R\/TMEM97 in retinal ganglion cell degeneration"],"prefix":"10.1038","volume":"12","author":[{"given":"Hua","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiyou","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiwen","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James J.","family":"Sahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy R.","family":"Hodges","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsung-Han","family":"Chou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuezhi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuliang","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vittorio","family":"Porciatti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel J.","family":"Liebl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen F.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,12,1]]},"reference":[{"key":"24537_CR1","first-page":"517","volume":"197","author":"WR Martin","year":"1976","unstructured":"Martin, W. R., Eades, C. G., Thompson, J. A., Huppler, R. E. & Gilbert, P. E. The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog. J. Pharmacol. Exp. Ther. 197, 517\u2013532 (1976).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"24537_CR2","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/0165-6147(92)90030-a","volume":"13","author":"R Quirion","year":"1992","unstructured":"Quirion, R. et al. A proposal for the classification of sigma binding sites. Trends Pharmacol. Sci. 13, 85\u201386. https:\/\/doi.org\/10.1016\/0165-6147(92)90030-a (1992).","journal-title":"Trends Pharmacol. Sci."},{"key":"24537_CR3","volume-title":"Sigma Receptors","author":"RR Matsumoto","year":"2007","unstructured":"Matsumoto, R. R. In Sigma Receptors (eds Su, T. P. et al.) (Springer, 2007)."},{"key":"24537_CR4","first-page":"284","volume":"223","author":"TP Su","year":"1982","unstructured":"Su, T. P. Evidence for sigma opioid receptor: Binding of [3H]SKF-10047 to etorphine-inaccessible sites in guinea-pig brain. J. Pharmacol. Exp. Ther. 223, 284\u2013290 (1982).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"24537_CR5","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/0006-8993(90)91143-5","volume":"527","author":"SB Hellewell","year":"1990","unstructured":"Hellewell, S. B. & Bowen, W. D. A sigma-like binding site in rat pheochromocytoma (PC12) cells: Decreased affinity for (+)-benzomorphans and lower molecular weight suggest a different sigma receptor form from that of guinea pig brain. Brain Res. 527, 244\u2013253. https:\/\/doi.org\/10.1016\/0006-8993(90)91143-5 (1990).","journal-title":"Brain Res."},{"key":"24537_CR6","doi-asserted-by":"publisher","first-page":"8072","DOI":"10.1073\/pnas.93.15.8072","volume":"93","author":"M Hanner","year":"1996","unstructured":"Hanner, M. et al. Purification, molecular cloning, and expression of the mammalian sigma1-binding site. Proc. Natl. Acad. Sci. USA 93, 8072\u20138077. https:\/\/doi.org\/10.1073\/pnas.93.15.8072 (1996).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"24537_CR7","doi-asserted-by":"publisher","first-page":"7160","DOI":"10.1073\/pnas.1705154114","volume":"114","author":"A Alon","year":"2017","unstructured":"Alon, A. et al. Identification of the gene that codes for the sigma2 receptor. Proc. Natl. Acad. Sci. USA 114, 7160\u20137165. https:\/\/doi.org\/10.1073\/pnas.1705154114 (2017).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"24537_CR8","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/s41586-021-04175-x","volume":"600","author":"A Alon","year":"2021","unstructured":"Alon, A. et al. Structures of the sigma2 receptor enable docking for bioactive ligand discovery. Nature 600, 759\u2013764. https:\/\/doi.org\/10.1038\/s41586-021-04175-x (2021).","journal-title":"Nature"},{"key":"24537_CR9","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1038\/s41589-021-00907-2","volume":"17","author":"YS Cheng","year":"2021","unstructured":"Cheng, Y. S. et al. A proteome-wide map of 20(S)-hydroxycholesterol interactors in cell membranes. Nat. Chem. Biol. 17, 1271\u20131280. https:\/\/doi.org\/10.1038\/s41589-021-00907-2 (2021).","journal-title":"Nat. Chem. Biol."},{"key":"24537_CR10","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.14670\/HH-19.1021","volume":"19","author":"H Kayed","year":"2004","unstructured":"Kayed, H. et al. Expression analysis of MAC30 in human pancreatic cancer and tumors of the gastrointestinal tract. Histol. Histopathol. 19, 1021\u20131031. https:\/\/doi.org\/10.14670\/HH-19.1021 (2004).","journal-title":"Histol. Histopathol."},{"key":"24537_CR11","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1074\/mcp.M113.035600","volume":"13","author":"L Fagerberg","year":"2014","unstructured":"Fagerberg, L. et al. Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics. Mol. Cell Proteom. 13, 397\u2013406. https:\/\/doi.org\/10.1074\/mcp.M113.035600 (2014).","journal-title":"Mol. Cell Proteom."},{"key":"24537_CR12","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/s0306-4522(96)00221-7","volume":"76","author":"P Bouchard","year":"1997","unstructured":"Bouchard, P. & Quirion, R. [3H]1,3-di(2-tolyl)guanidine and [3H](+)pentazocine binding sites in the rat brain: Autoradiographic visualization of the putative sigma1 and sigma2 receptor subtypes. Neuroscience 76, 467\u2013477. https:\/\/doi.org\/10.1016\/s0306-4522(96)00221-7 (1997).","journal-title":"Neuroscience"},{"key":"24537_CR13","first-page":"900","volume":"292","author":"BJ Vilner","year":"2000","unstructured":"Vilner, B. J. & Bowen, W. D. Modulation of cellular calcium by sigma-2 receptors: Release from intracellular stores in human SK-N-SH neuroblastoma cells. J Pharmacol. Exp. Ther. 292, 900\u2013911 (2000).","journal-title":"J Pharmacol. Exp. Ther."},{"key":"24537_CR14","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.cmet.2009.05.009","volume":"10","author":"F Bartz","year":"2009","unstructured":"Bartz, F. et al. Identification of cholesterol-regulating genes by targeted RNAi screening. Cell Metab. 10, 63\u201375. https:\/\/doi.org\/10.1016\/j.cmet.2009.05.009 (2009).","journal-title":"Cell Metab."},{"key":"24537_CR15","doi-asserted-by":"publisher","first-page":"3588","DOI":"10.1093\/hmg\/ddw204","volume":"25","author":"D Ebrahimi-Fakhari","year":"2016","unstructured":"Ebrahimi-Fakhari, D. et al. Reduction of TMEM97 increases NPC1 protein levels and restores cholesterol trafficking in Niemann-pick type C1 disease cells. Hum. Mol. Genet. 25, 3588\u20133599. https:\/\/doi.org\/10.1093\/hmg\/ddw204 (2016).","journal-title":"Hum. Mol. Genet."},{"key":"24537_CR16","doi-asserted-by":"publisher","first-page":"16845","DOI":"10.1038\/s41598-018-35430-3","volume":"8","author":"A Riad","year":"2018","unstructured":"Riad, A. et al. Sigma-2 receptor\/TMEM97 and PGRMC-1 increase the rate of internalization of LDL by LDL receptor through the formation of a ternary complex. Sci. Rep. 8, 16845. https:\/\/doi.org\/10.1038\/s41598-018-35430-3 (2018).","journal-title":"Sci. Rep."},{"key":"24537_CR17","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1054\/bjoc.1999.1067","volume":"82","author":"KT Wheeler","year":"2000","unstructured":"Wheeler, K. T. et al. Sigma-2 receptors as a biomarker of proliferation in solid tumours. Br. J. Cancer 82, 1223\u20131232. https:\/\/doi.org\/10.1054\/bjoc.1999.1067 (2000).","journal-title":"Br. J. Cancer"},{"key":"24537_CR18","doi-asserted-by":"publisher","first-page":"3519","DOI":"10.2174\/138161210793563365","volume":"16","author":"A van Waarde","year":"2010","unstructured":"van Waarde, A. et al. Sigma receptors in oncology: Therapeutic and diagnostic applications of sigma ligands. Curr. Pharm. Des. 16, 3519\u20133537. https:\/\/doi.org\/10.2174\/138161210793563365 (2010).","journal-title":"Curr. Pharm. Des."},{"key":"24537_CR19","doi-asserted-by":"publisher","first-page":"7137","DOI":"10.1021\/jm301545c","volume":"56","author":"RH Mach","year":"2013","unstructured":"Mach, R. H., Zeng, C. & Hawkins, W. G. The sigma2 receptor: A novel protein for the imaging and treatment of cancer. J. Med. Chem. 56, 7137\u20137160. https:\/\/doi.org\/10.1021\/jm301545c (2013).","journal-title":"J. Med. Chem."},{"key":"24537_CR20","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.3389\/fphar.2018.01345","volume":"9","author":"K Schmit","year":"2018","unstructured":"Schmit, K. & Michiels, C. TMEM proteins in cancer: A review. Front. Pharmacol. 9, 1345. https:\/\/doi.org\/10.3389\/fphar.2018.01345 (2018).","journal-title":"Front. Pharmacol."},{"key":"24537_CR21","doi-asserted-by":"publisher","first-page":"7926","DOI":"10.1021\/acs.jmedchem.0c02265","volume":"64","author":"AN Fallica","year":"2021","unstructured":"Fallica, A. N. et al. Recent advances in the development of sigma receptor ligands as cytotoxic agents: A medicinal chemistry perspective. J. Med. Chem. 64, 7926\u20137962. https:\/\/doi.org\/10.1021\/acs.jmedchem.0c02265 (2021).","journal-title":"J. Med. Chem."},{"key":"24537_CR22","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.3390\/cancers12071877","volume":"12","author":"C Zeng","year":"2020","unstructured":"Zeng, C., Riad, A. & Mach, R. H. The biological function of sigma-2 receptor\/TMEM97 and its utility in PET imaging studies in cancer. Cancers 12, 1877. https:\/\/doi.org\/10.3390\/cancers12071877 (2020).","journal-title":"Cancers"},{"key":"24537_CR23","first-page":"156","volume":"57","author":"RH Mach","year":"1997","unstructured":"Mach, R. H. et al. Sigma 2 receptors as potential biomarkers of proliferation in breast cancer. Cancer Res. 57, 156\u2013161 (1997).","journal-title":"Cancer Res."},{"key":"24537_CR24","doi-asserted-by":"publisher","first-page":"989","DOI":"10.2174\/0929867322666150114163607","volume":"22","author":"L Guo","year":"2015","unstructured":"Guo, L. & Zhen, X. Sigma-2 receptor ligands: Neurobiological effects. Curr. Med. Chem. 22, 989\u20131003. https:\/\/doi.org\/10.2174\/0929867322666150114163607 (2015).","journal-title":"Curr. Med. Chem."},{"key":"24537_CR25","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1111\/jnc.13917","volume":"140","author":"B Yi","year":"2017","unstructured":"Yi, B. et al. Small molecule modulator of sigma 2 receptor is neuroprotective and reduces cognitive deficits and neuroinflammation in experimental models of Alzheimer\u2019s disease. J. Neurochem. 140, 561\u2013575. https:\/\/doi.org\/10.1111\/jnc.13917 (2017).","journal-title":"J. Neurochem."},{"key":"24537_CR26","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1021\/acschemneuro.8b00543","volume":"10","author":"E Vazquez-Rosa","year":"2019","unstructured":"Vazquez-Rosa, E. et al. Neuroprotective efficacy of a sigma 2 receptor\/tmem97 modulator (DKR-1677) after traumatic brain injury. ACS Chem. Neurosci. 10, 1595\u20131602. https:\/\/doi.org\/10.1021\/acschemneuro.8b00543 (2019).","journal-title":"ACS Chem. Neurosci."},{"key":"24537_CR27","doi-asserted-by":"publisher","first-page":"4611","DOI":"10.1167\/iovs.04-0541","volume":"45","author":"GT Prusky","year":"2004","unstructured":"Prusky, G. T., Alam, N. M., Beekman, S. & Douglas, R. M. Rapid quantification of adult and developing mouse spatial vision using a virtual optomotor system. Invest. Ophthalmol. Vis. Sci. 45, 4611\u20134616. https:\/\/doi.org\/10.1167\/iovs.04-0541 (2004).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"24537_CR28","doi-asserted-by":"publisher","first-page":"9708","DOI":"10.1038\/s41598-018-27329-w","volume":"8","author":"C Shi","year":"2018","unstructured":"Shi, C. et al. Optimization of optomotor response-based visual function assessment in mice. Sci. Rep. 8, 9708. https:\/\/doi.org\/10.1038\/s41598-018-27329-w (2018).","journal-title":"Sci. Rep."},{"key":"24537_CR29","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1038\/nbt822","volume":"21","author":"DM Valenzuela","year":"2003","unstructured":"Valenzuela, D. M. et al. High-throughput engineering of the mouse genome coupled with high-resolution expression analysis. Nat. Biotechnol. 21, 652\u2013659. https:\/\/doi.org\/10.1038\/nbt822 (2003).","journal-title":"Nat. Biotechnol."},{"key":"24537_CR30","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1002\/cne.23521","volume":"522","author":"AR Rodriguez","year":"2014","unstructured":"Rodriguez, A. R., de Sevilla Muller, L. P. & Brecha, N. C. The RNA binding protein RBPMS is a selective marker of ganglion cells in the mammalian retina. J. Comp. Neurol. 522, 1411\u20131443. https:\/\/doi.org\/10.1002\/cne.23521 (2014).","journal-title":"J. Comp. Neurol."},{"key":"24537_CR31","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.exer.2015.05.008","volume":"141","author":"V Porciatti","year":"2015","unstructured":"Porciatti, V. Electrophysiological assessment of retinal ganglion cell function. Exp. Eye Res. 141, 164\u2013170. https:\/\/doi.org\/10.1016\/j.exer.2015.05.008 (2015).","journal-title":"Exp. Eye Res."},{"key":"24537_CR32","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.trci.2018.11.001","volume":"5","author":"M Grundman","year":"2019","unstructured":"Grundman, M. et al. A phase 1 clinical trial of the sigma-2 receptor complex allosteric antagonist CT1812, a novel therapeutic candidate for Alzheimer\u2019s disease. Alzheimers Dement. (N Y) 5, 20\u201326. https:\/\/doi.org\/10.1016\/j.trci.2018.11.001 (2019).","journal-title":"Alzheimers Dement. (N Y)"},{"key":"24537_CR33","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/s1350-9462(03)00027-2","volume":"22","author":"S Isenmann","year":"2003","unstructured":"Isenmann, S., Kretz, A. & Cellerino, A. Molecular determinants of retinal ganglion cell development, survival, and regeneration. Prog. Retina Eye Res. 22, 483\u2013543. https:\/\/doi.org\/10.1016\/s1350-9462(03)00027-2 (2003).","journal-title":"Prog. Retina Eye Res."},{"key":"24537_CR34","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1002\/dneu.22559","volume":"78","author":"J Beros","year":"2018","unstructured":"Beros, J., Rodger, J. & Harvey, A. R. Developmental retinal ganglion cell death and retinotopicity of the murine retinocollicular projection. Dev. Neurobiol. 78, 51\u201360. https:\/\/doi.org\/10.1002\/dneu.22559 (2018).","journal-title":"Dev. Neurobiol."},{"key":"24537_CR35","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.preteyeres.2018.07.003","volume":"67","author":"SB Smith","year":"2018","unstructured":"Smith, S. B. et al. Sigma 1 receptor: A novel therapeutic target in retinal disease. Prog. Retina Eye Res. 67, 130\u2013149. https:\/\/doi.org\/10.1016\/j.preteyeres.2018.07.003 (2018).","journal-title":"Prog. Retina Eye Res."},{"key":"24537_CR36","doi-asserted-by":"publisher","first-page":"7749","DOI":"10.1167\/iovs.11-8169","volume":"52","author":"Y Ha","year":"2011","unstructured":"Ha, Y. et al. Late-onset inner retinal dysfunction in mice lacking sigma receptor 1 (sigmaR1). Invest. Ophthalmol. Vis. Sci. 52, 7749\u20137760. https:\/\/doi.org\/10.1167\/iovs.11-8169 (2011).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"24537_CR37","doi-asserted-by":"publisher","first-page":"21975","DOI":"10.1038\/s41598-021-01077-w","volume":"11","author":"M Geva","year":"2021","unstructured":"Geva, M. et al. Neuroprotection of retinal ganglion cells by the sigma-1 receptor agonist pridopidine in models of experimental glaucoma. Sci. Rep. 11, 21975. https:\/\/doi.org\/10.1038\/s41598-021-01077-w (2021).","journal-title":"Sci. Rep."},{"key":"24537_CR38","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1038\/s41386-018-0067-z","volume":"43","author":"LL Scott","year":"2018","unstructured":"Scott, L. L. et al. Small molecule modulators of sigma2R\/Tmem97 reduce alcohol withdrawal-induced behaviors. Neuropsychopharmacology 43, 1867\u20131875. https:\/\/doi.org\/10.1038\/s41386-018-0067-z (2018).","journal-title":"Neuropsychopharmacology"},{"key":"24537_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2020.108409","volume":"184","author":"SG Quadir","year":"2021","unstructured":"Quadir, S. G. et al. The Sigma-2 receptor \/ transmembrane protein 97 (sigma2R\/TMEM97) modulator JVW-1034 reduces heavy alcohol drinking and associated pain states in male mice. Neuropharmacology 184, 108409. https:\/\/doi.org\/10.1016\/j.neuropharm.2020.108409 (2021).","journal-title":"Neuropharmacology"},{"key":"24537_CR40","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/syn.21717","volume":"68","author":"JR Lever","year":"2014","unstructured":"Lever, J. R. et al. A selective sigma-2 receptor ligand antagonizes cocaine-induced hyperlocomotion in mice. Synapse 68, 73\u201384. https:\/\/doi.org\/10.1002\/syn.21717 (2014).","journal-title":"Synapse"},{"key":"24537_CR41","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1021\/acschemneuro.7b00200","volume":"8","author":"JJ Sahn","year":"2017","unstructured":"Sahn, J. J., Mejia, G. L., Ray, P. R., Martin, S. F. & Price, T. J. Sigma 2 receptor\/Tmem97 agonists produce long lasting antineuropathic pain effects in mice. ACS Chem. Neurosci. 8, 1801\u20131811. https:\/\/doi.org\/10.1021\/acschemneuro.7b00200 (2017).","journal-title":"ACS Chem. Neurosci."},{"key":"24537_CR42","doi-asserted-by":"publisher","DOI":"10.1101\/2020.07.10.198143","author":"J-H Wang","year":"2020","unstructured":"Wang, J.-H. et al. Functional study of the AMD-associated gene TMEM97 in retinal pigmented epithelium using CRISPR interference. bioRxiv https:\/\/doi.org\/10.1101\/2020.07.10.198143 (2020).","journal-title":"bioRxiv"},{"key":"24537_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2021.110078","volume":"86","author":"H Shen","year":"2021","unstructured":"Shen, H. et al. TMEM97 ablation aggravates oxidant-induced retinal degeneration. Cell Signal 86, 110078. https:\/\/doi.org\/10.1016\/j.cellsig.2021.110078 (2021).","journal-title":"Cell Signal"},{"key":"24537_CR44","volume-title":"Webvision: The Organization of the Retina and Visual System","author":"R Nelson","year":"1995","unstructured":"Nelson, R. In Webvision: The Organization of the Retina and Visual System (eds Kolb, H. et al.) (Moran Eye Center, 1995)."},{"key":"24537_CR45","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.preteyeres.2003.12.001","volume":"23","author":"NN Osborne","year":"2004","unstructured":"Osborne, N. N. et al. Retinal ischemia: Mechanisms of damage and potential therapeutic strategies. Prog. Retina Eye Res. 23, 91\u2013147. https:\/\/doi.org\/10.1016\/j.preteyeres.2003.12.001 (2004).","journal-title":"Prog. Retina Eye Res."},{"key":"24537_CR46","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/eye.2016.299","volume":"31","author":"TZ Khatib","year":"2017","unstructured":"Khatib, T. Z. & Martin, K. R. Protecting retinal ganglion cells. Eye (Lond.) 31, 218\u2013224. https:\/\/doi.org\/10.1038\/eye.2016.299 (2017).","journal-title":"Eye (Lond.)"},{"key":"24537_CR47","doi-asserted-by":"publisher","first-page":"R139","DOI":"10.1093\/hmg\/ddx273","volume":"26","author":"V Carelli","year":"2017","unstructured":"Carelli, V., La Morgia, C., Ross-Cisneros, F. N. & Sadun, A. A. Optic neuropathies: The tip of the neurodegeneration iceberg. Hum. Mol. Genet. 26, R139\u2013R150. https:\/\/doi.org\/10.1093\/hmg\/ddx273 (2017).","journal-title":"Hum. Mol. Genet."},{"key":"24537_CR48","volume-title":"Webvision","author":"D Krizaj","year":"1995","unstructured":"Krizaj, D. In Webvision (eds Kolb, H. et al.) (Moran Eye Center, 1995)."},{"key":"24537_CR49","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1136\/bjo.86.2.238","volume":"86","author":"PJ Foster","year":"2002","unstructured":"Foster, P. J., Buhrmann, R., Quigley, H. A. & Johnson, G. J. The definition and classification of glaucoma in prevalence surveys. Br. J. Ophthalmol. 86, 238\u2013242. https:\/\/doi.org\/10.1136\/bjo.86.2.238 (2002).","journal-title":"Br. J. Ophthalmol."},{"key":"24537_CR50","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1016\/S0140-6736(17)31469-1","volume":"390","author":"JB Jonas","year":"2017","unstructured":"Jonas, J. B. et al. Glaucoma. Lancet 390, 2183\u20132193. https:\/\/doi.org\/10.1016\/S0140-6736(17)31469-1 (2017).","journal-title":"Lancet"},{"key":"24537_CR51","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1146\/annurev.neuro.051508.135728","volume":"35","author":"RW Nickells","year":"2012","unstructured":"Nickells, R. W., Howell, G. R., Soto, I. & John, S. W. Under pressure: Cellular and molecular responses during glaucoma, a common neurodegeneration with axonopathy. Annu. Rev. Neurosci. 35, 153\u2013179. https:\/\/doi.org\/10.1146\/annurev.neuro.051508.135728 (2012).","journal-title":"Annu. Rev. Neurosci."},{"key":"24537_CR52","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.3390\/ijms21072262","volume":"21","author":"R Boia","year":"2020","unstructured":"Boia, R. et al. Neuroprotective strategies for retinal ganglion cell degeneration: Current status and challenges ahead. Int. J. Mol. Sci. 21, 2262. https:\/\/doi.org\/10.3390\/ijms21072262 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"24537_CR53","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/0014-4835(75)90080-9","volume":"21","author":"MM LaVail","year":"1975","unstructured":"LaVail, M. M. & Battelle, B. A. Influence of eye pigmentation and light deprivation on inherited retinal dystrophy in the rat. Exp. Eye Res. 21, 167\u2013192. https:\/\/doi.org\/10.1016\/0014-4835(75)90080-9 (1975).","journal-title":"Exp. Eye Res."},{"key":"24537_CR54","doi-asserted-by":"publisher","first-page":"4069","DOI":"10.1167\/iovs.02-1130","volume":"44","author":"Y Song","year":"2003","unstructured":"Song, Y. et al. Photoreceptor protection by cardiotrophin-1 in transgenic rats with the rhodopsin mutation s334ter. Invest. Ophthalmol. Vis. Sci. 44, 4069\u20134075 (2003).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"24537_CR55","doi-asserted-by":"publisher","first-page":"2469","DOI":"10.1167\/iovs.14-13943","volume":"55","author":"TH Chou","year":"2014","unstructured":"Chou, T. H., Bohorquez, J., Toft-Nielsen, J., Ozdamar, O. & Porciatti, V. Robust mouse pattern electroretinograms derived simultaneously from each eye using a common snout electrode. Invest. Ophthalmol. Vis. Sci. 55, 2469\u20132475. https:\/\/doi.org\/10.1167\/iovs.14-13943 (2014).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"24537_CR56","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1167\/iovs.62.9.9","volume":"62","author":"R Amato","year":"2021","unstructured":"Amato, R. et al. Diabetes exacerbates the intraocular pressure-independent retinal ganglion cells degeneration in the DBA\/2J model of glaucoma. Invest. Ophthalmol. Vis. Sci. 62, 9. https:\/\/doi.org\/10.1167\/iovs.62.9.9 (2021).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"24537_CR57","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1021\/acsmedchemlett.7b00066","volume":"8","author":"JJ Sahn","year":"2017","unstructured":"Sahn, J. J., Hodges, T. R., Chan, J. Z. & Martin, S. F. Norbenzomorphan scaffold: Chemical tool for modulating sigma receptor-subtype selectivity. ACS Med. Chem. Lett. 8, 455\u2013460. https:\/\/doi.org\/10.1021\/acsmedchemlett.7b00066 (2017).","journal-title":"ACS Med. Chem. Lett."},{"key":"24537_CR58","doi-asserted-by":"publisher","first-page":"13523","DOI":"10.1523\/JNEUROSCI.4021-06.2006","volume":"26","author":"R Wen","year":"2006","unstructured":"Wen, R. et al. Regulation of rod phototransduction machinery by ciliary neurotrophic factor. J. Neurosci. 26, 13523\u201313530. https:\/\/doi.org\/10.1523\/JNEUROSCI.4021-06.2006 (2006).","journal-title":"J. Neurosci."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-24537-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-24537-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-24537-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T13:22:48Z","timestamp":1669900968000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-24537-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,1]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["24537"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-24537-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,1]]},"assertion":[{"value":"10 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare the following competing financial interest(s): S.F.M., J.J.S., and T.R.H. are co-inventors of pending patent applications related to the work described in this article. S.F.M. and J.J.S. are cofounders of NuvoNuro, Inc. H.W., Z.P., Y.L., T.H.C., Q.L., X.Z., S.J., V.P., D.J.L., and R.W. do not have any competing interests to declare.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20753"}}